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Intake of Coffee and Tea and Risk of Ovarian Cancer: A Prospective
Cohort Study
Stephanie A. N. Silvera, Meera Jain, Geoffrey R. Howe, Anthony B. Miller,
and Thomas E. Rohan
Abstract: There is some evidence from case-control studies
that coffee consumption might be positively associated with
ovarian cancer risk, whereas the epidemiologic evidence re-
garding tea consumption and ovarian cancer is inconsistent.
To date, there have been few prospective studies of these as-
sociations. Therefore, we examined ovarian cancer risk in
association with both coffee and tea intake in a prospec-
tive cohort study of 49,613 Canadian women enrolled in
the National Breast Screening Study (NBSS) who completed
a self-administered food frequency questionnaire between
1980 and 1985. Linkages to national mortality and cancer
databases yielded data on deaths and cancer incidence, with
follow-up ending between 1998 and 2000. Data from the food
frequency questionnaire were used to estimate daily intake
of coffee and tea. Cox proportional hazards models were
used to estimate hazard ratios (HR) and 95% confidence in-
tervals (CI) for the association between categories of coffee
and tea intake and ovarian cancer risk. During a mean 16.4
years of follow-up, we observed 264 incident ovarian cancer
cases. Tea intake was not associated with ovarian cancer
risk in our study population. In contrast, a borderline posi-
tive association was observed among women who drank >4
cups coffee/day compared to women who did not drink coffee
(HR = 1.62, 95% CI = 0.95–2.75, Ptrend = 0.06). Given the
pervasive use of these beverages, the associations between
coffee and tea consumption and ovarian cancer risk warrant
investigation in further prospective studies.
Introduction
Coffee and tea are widely consumed throughout the world.
Hence it is of interest to know if they have any effects on
health. Many outcomes have been examined in relation to
coffee and tea consumption, including hypertension, coro-
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nary heart disease, and various cancers (1–3). In relation to
cancer, some of the volatile components of coffee, includ-
ing caffeine, may be carcinogenic to humans (4), whereas
tea has tumor-inhibitory effects in several organs (including
skin, oral cavity, lung, esophagus, stomach, small intestine,
pancreas, and mammary gland) (5).
Ovarian cancer is the leading cause of fatality among gy-
necological malignancies. However, relatively little is known
about its etiology (6). There is some biological support for the
possibility that coffee and tea consumption might influence
ovarian cancer risk. While caffeine may enhance or mimic
the effect of gonadotropins, which are thought to increase the
risk of ovarian cancer (4), tea and some of its components
have been shown to be inversely associated with circulating
estrogen levels (7,8), which are thought to increase prolifera-
tion and malignant transformation of ovarian epithelial cells
(9).
To date, it appears that the relationship between coffee
intake and ovarian cancer risk has been examined in ten case-
control studies (4,10–18) and three prospective cohort studies
(10–12). In two of those prospective investigations no asso-
ciation was observed (10,11) while the other one (12) found
a non-significant increased risk. Most case-control studies
of coffee intake and ovarian cancer risk have reported pos-
itive associations, although the increases in risk have gen-
erally been small (13). The results of case-control studies
of tea intake and ovarian cancer risk have been inconsistent
(4,11,14,23–26) and the two prospective cohort studies to
date have reported a decrease in risk associated with rela-
tively high tea consumption (14,15). The results of previous
studies are summarized in Table 1.
Given the paucity of prospective data, we examined the
relationship between coffee and tea intake and ovarian can-
cer risk in a large prospective cohort study of Canadian
women.
Table 1. Summary of Previous Epidemiologic Studies of Tea and Alcohol Consumption and Ovarian Cancer Risk
Number of Number of Controls/
Reference Study Design Cases Non-Cases Comparison Risk estimate (95% CI)
Tea Consumption
Byers et al., 1983 (39) Case-control 274 1034 > 3 C/day vs. none 0.84 (ns)
Miller et al., 1987 (40) Case-control 290 1056 > 5 C/day vs. none 0.5 (0.2–1.0)
LaVecchia et al., 1992 (24) Case-control 742 6417 > 1 C/day vs. none 1.2 ( 1.0–1.4)
Kuper et al., 2000 (4) Case-control 563 523 > weekly vs. never 1.06 (0.83–1.36)
Tavani et al., 2001 (22) Case-control 1031 2411 > 1C/month vs. none 0.9 (0.75–1.08)
Zhang et al., 2002 (29) Case-control 254 601 > 1 C/day vs. none 0.39 (0.27–0.57)
Jordan et al., 2004 (23) Case-control 696 786 > 4 C/day vs. never 1.10 (0.76–1.61)
Zheng et al., 1996 (14) Prospective Cohort 107 Cohort of 35,369 Weekly vs. none 0.53 (0.49–1.84)
Larsson et al., 2005 (10) Prospective Cohort 301 Cohort of 66,651 > 2 C/day vs. <1 C/day 0.54 (0.31–0.91)
Coffee Consumption
Trichopoulos et al., 1981 (41) Case-control 92 105 > 3C/day vs. none 2.2
Hartge et al., 1982 (42) Case-control 158 187 > 4C/day vs. none 1.4 (0.6–3.0)
Byers et al., 1983 (39) Case-control 274 1034 > 3C/day vs. none 0.97
Cramer et al., 1984 (43) Case-control 215 215 > 5C/day vs. none 1.5
LaVecchia et al., 1984 (44) Case-control 247 494 > 4C/day vs. none 2.2 (1.2–1.4)
Tzonou et al., 1984 (45) Case-control 150 250 > 3.5C/day vs. none 1.5
Miller et al., 1987 (40) Case-control 290 580 > 5C/day vs. none 1.1 (0.6–2.0)
Whittemore et al., 1988 (46) Case-control 188 539 > 4C/day vs. none 2.07 (0.97–4.38)
Polychronopoulou et al., 1993 (47) Case-control 189 200 > 2C/day vs. none 1.09 (0.52–2.27)
Kuper et al., 2000 (4) Case-control 549 516 >4C/day vs. none 1.88 (1.14–3.09)
Snowdon & Philips, 1984 (11) Prospective Cohort 50 Cohort of 16,190 > 1C/day vs. < 1 1.2 (0.6–2.5)
Stensvold et al., 1994 (12) Prospective Cohort 93 Cohort of 21,238 > 7C/day vs. < 2 2.0
Larsson et al., 2005 (10) Prospective Cohort 301 Cohort of 66,651 > 4C/day vs. none 1.02 (0.62–1.69)
Methods
Study Population
The design of the study has been described in detail else-
where (16). Briefly, 89,835 women aged 40–59 yr were re-
cruited into the Canadian National Breast Screening Study
(NBSS) between 1980 and 1985 from the general Canadian
population by various means, including personal invitation
by letter, group mailings to employees of large institutions
and to members of professional associations, advertisements
in newspapers, and public service announcements on radio
and television (17).
Questionnaires
At recruitment into the cohort, participants completed
self-administered questionnaires that sought information on
demographic characteristics, lifestyle factors, menstrual and
reproductive history, and use of oral contraceptives and re-
placement estrogens. Women who reported having regular
menstrual periods within the past 12 mo were classified as
premenopausal. Women whose menstrual periods ceased at
least 12 mo before enrollment into the study were considered
to be postmenopausal (18).
Starting in 1982 (that is, after some participants had com-
pleted their scheduled visits to the screening centers), a self-
administered food frequency questionnaire (FFQ) was dis-
tributed to all new attendees at all screening centers and to
women returning to the screening centers for re-screening
(19). The FFQ sought information on usual portion size and
frequency of consumption of 86 food items, and included
photographs of various portion sizes to assist respondents
with quantifying intake. As part of the FFQ women were
queried about usual frequency and amount of coffee and
tea consumed. A comparison between the self-administered
questionnaire and a full interviewer-administered question-
naire, which has been subjected to both validity and relia-
bility testing (19) and used in a number of epidemiologic
studies (20), revealed that the two methods gave estimates
of intake of the major macro-nutrients which were moder-
ately to strongly correlated with each other (reported corre-
lation coefficients ranged from 0.47 to 0.72) (19). A total of
49,613 dietary questionnaires were returned and available for
analysis.
Ascertainment of Incident Ovarian Cancer Cases
and Deaths
Incident ovarian cancer cases and deaths amongst cohort
members were ascertained respectively by means of comput-
erized record linkages to the Canadian Cancer Database and
to the National Mortality Database, both of which are main-
tained by Statistics Canada. The linkages to the databases
yielded data on cancer incidence and mortality to December
31, 2000, for women in Ontario, December 31, 1998, for
women in Quebec, and December 31, 1999, for women in
other provinces.
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Table 2. Baseline Characteristics of the Study Population by Outcome
Cases of incident ovarian cancer (n = 264) Non-cases (n = 48,508)
Mean age (yr) 49.7 (5.7)‡ 48.6 (5.6)
Mean coffee intake (cups/day) 2.3 (2.0) 2.1 (2.0)
Mean tea intake (cups/day) 1.4 (1.6) 1.4 (1.7)
Mean education (yr) 13.2 (3.0) 12.8 (3.0)
Mean body mass index (kg/m2) 24.5 (4.2) 24.8 (4.6)
Parity (% parous) 78.0 85.2
Mean age at first live birth (yr)¥ 24.6 (4.6) 24.3 (4.7)
Mean age at menarche (yr) 12.8 (1.5) 12.8 (2.0)
Menopausal status (% postmenopausal) 46.8 42.8
Smoking history (% ever) 52.6 48.5
Any alcohol intake (%) 74.6 73.9
Any vigorous physical activity (%) 75.7 71.0
‡ Numbers in parentheses represent the standard deviation.
¥ Among parous women only.
Statistical Analysis
Of the 49,613 women for whom dietary data were avail-
able, we excluded women with extreme energy intake values
(at least three standard deviations above or below the mean
value for loge caloric intake) (n = 502); women with preva-
lent ovarian cancer at baseline (n = 20); and women who re-
ported at baseline that they had had a bilateral oophorectomy
(n = 315). These exclusions left 48,776 women available for
analysis, among whom there were 264 incident cases of ovar-
ian cancer. Study participants were considered to be at risk
from their date of enrollment until the date of diagnosis of
ovarian cancer, the date of termination of follow-up (the date
to which cancer incidence data were available for women in
the corresponding province), or the date of death, whichever
occurred earliest.
Cox proportional hazards models (using age as the time
scale) were used to estimate hazard ratios (HR) and 95%
confidence intervals (CI) for the association between coffee
and tea intake (separately) and ovarian cancer risk. For these
analyses, coffee and tea intake were categorized to create 4-
level variables (none, and three non-zero levels). Multivariate
models included the variables listed in the footnotes to Table
2. To test for trends in risk with increasing levels of the
exposures of interest, we assigned the coffee and tea intake
categories their ordinal number and then fitted the assigned
value of each risk factor as a continuous variable in the risk
models. We then evaluated the statistical significance of the
corresponding coefficient using the Wald test (21). Use of
the lifetest procedure in SAS? showed that the proportional
hazards assumption was met in this dataset. All analyses were
performed using SAS version 9 (SAS Institute, Cary, NC).
Results
The average duration of follow-up for cohort members
was 16.4 yr, corresponding to a total of 801,414 person-
years of follow-up. The mean (SD) age at diagnosis for the
cases was 59.4 (± 7.2) years. For the cohort as a whole, the
mean (± SD) coffee intake was 2.1 cups/day (± 2.0) and the
mean tea intake was 1.4 cups/day (± 1.7). Compared with
non-cases, ovarian cancer cases were less likely to be parous
at baseline, and more likely to have ever smoked and to have
participated in any vigorous physical activity (Table 2). No
appreciable difference was observed in mean age at baseline,
body mass index, age at menarche, alcohol intake, or age at
first birth by case status at the end of follow-up.
Table 3 shows that in both age- and multivariate-adjusted
models, ovarian cancer risk varied little in association with
tea intake. In contrast, women who drank >4 cups of
Table 3. Adjusted Hazard Ratios§ and 95% Confidence
Intervals (CI) for the Association Between Daily Coffee
and Tea Intake and Risk of Ovarian Cancer
Age-adjusted Multivariate
Intake Cases/
(cups/day) Person Years HR 95% CI HR 95% CI
Coffee
None 34/126,119 1.00 Referent 1.00 Referent
>0 – <=1 110/362,997 1.14 0.77–1.68 1.18 0.76–1.83
2–3 79/217,426 1.36 0.91–2.05 1.36 0.86–2.15
> 4 41/94,853 1.66 1.04–2.64 1.62 0.95–2.75
Ptrend 0.02 0.06
Tea
None 61/179,331 1.00 Referent 1.00 Referent
>0 – <=1 143/449,340 0.90 0.66–1.22 0.86 0.63–1.18
2–3 38/121,890 0.86 0.57–1.29 0.81 0.53–1.23
> 4 22/50,834 1.18 0.72–1.93 1.07 0.64–1.79
Ptrend 0.90 0.77
§ Multivariate models included age (time to event variable), smoking his-
tory (never, former, current), pack-years of smoking (never plus 4 non-zero
categories), alcohol intake (any vs. none), education (>12 yr vs. <=12
yr), BMI in kg/m2 (<25, 25–29, >30), parity (parous vs. nulliparous),
participation in vigorous physical activity (any vs. none), menopausal sta-
tus, oral contraceptive use (zero plus 3 non-zero categories), energy intake
(continuous), lactose intake (continuous), study center, and randomization
group.
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coffee/day had a 62% increase in ovarian cancer risk com-
pared to women who did not drink coffee (HR = 1.62, 95%
CI = 0.95–2.75, Ptrend = 0.06) in the multivariate model.
Mutual adjustment for both coffee and tea in a multivari-
ate model did not materially alter the hazard ratios for each
beverage (data not shown).
The results for each of the analyses presented above were
similar after exclusion of case subjects diagnosed within
1 yr of recruitment (n = 10).
Discussion
In the present cohort study, we observed a positive asso-
ciation between coffee intake and ovarian cancer risk over a
16-yr follow-up period. In contrast, there was no association
between tea consumption and risk.
Our findings for coffee consumption are similar to those of
the majority of previous case-control studies (4,10–18) and
to those of one (12) of the three (10–12) previous prospective
studies, the other two of which showed no association (10,11)
(Table 3). It is important to note that the caffeine levels in
coffee can range from 70–150 mg/cup due to differences in
brewing method and species of coffee used (13), which may
account, in part, for some of the conflicting findings in the
literature. With respect to tea consumption, our null finding
is in accord with those of three previous case-control studies
(4,22,23). However, the epidemiologic evidence concerning
the relationship between tea consumption and ovarian cancer
risk is inconsistent, given that one case-control study (24)
reported a weak positive association and there was some
evidence of an inverse association between tea and ovarian
cancer risk in three (14,24,25) case-control studies and two
prospective cohort studies (14,15).
Although the potential carcinogenicity of caffeine has
been the subject of much investigation, its role in cancer
development is unresolved (13). There is some evidence that
caffeine may affect DNA structure and function by inhi-
bition of poly(ADP-ribosyl)ation reactions, which are im-
portant in postreplication repair of damaged DNA (4), and
that it may potentiate DNA damage via inhibition of DNA
repair during the S and G2 phases of the cell cycle (25).
In addition to caffeine, coffee contains volatile substances
(heterocyclic rings containing oxygen, sulfur or nitrogen in-
cluding aldehydes) which may be carcinogenic to humans
(26). In contrast, coffee also contains lignans (27) and has
been shown to increase plasma enterolactone concentrations
(27) and serum equol concentrations (28). There is some ev-
idence that phytoestrogens (e.g., isoflavonoids and lignans)
with estrogen-like activities may be associated with a re-
duced risk of hormone-dependent neoplasms (28) and that
individuals with high serum equol concentrations may be at
lower risk for hormone dependant neoplasms such as breast
cancer (27). The potentially divergent effects of caffeine and
the phytoestrogen effect of coffee may explain, in part, the
conflicting literature. These possible mechanisms of action
are speculative and further research is needed to investigate
the potential role of caffeine in carcinogenesis.
In contrast to coffee, there is evidence from animal studies
that tea has anti-carcinogenic effects (3,29). In animal exper-
iments, tea polyphenols, the most likely anti-carcinogenic
agents in tea (3), have been shown to be absorbed from the
digestive tract and to reach various organs, including the
ovary, via the circulation (30). The concentration of antiox-
idative polyphenol compounds in tea varies according to the
type of tea (e.g., green, black, oolong) (3), with green tea
having greater total phenols and higher antioxidant capac-
ity than black tea (31). Therefore, differences in findings
from epidemiologic studies may be due to differences in the
types of tea consumed in different populations (29). In the
1980s (when data on tea consumption were collected for this
study), black tea was the predominant form of tea consumed
in North America, accounting for approximately 88% of all
the tea consumed (32). Currently black tea accounts for ap-
proximately 76–80% of all tea consumed in North America
(33,34) whereas green tea accounts for only 9% of all tea
consumed in the United States, up from 4% in 2001 (35). In
contrast, a survey in Japan has shown that 65% of the popula-
tion reported drinking green tea >5 times per week and 85%
report drinking green tea at least once per week (35). These
differences likely account for the discrepancy between our
findings and those from the cohort study of Zheng et al. (14).
Larsson et al. (15), however, examined black tea consumption
in a cohort study in Sweden and found a statistically signif-
icant reduced risk of ovarian cancer (Table 1). In addition,
there is evidence to suggest that the method of preparation
(hot vs. cold/iced) and the amount of dry tea used may influ-
ence the anticancer effects of tea by altering the concentration
of polyphenols (36,37). Differences in the method of prepa-
ration may account, in part, for the conflicting results in the
literature. Thus, future studies of tea consumption and cancer
risk should measure not only for the amount of intake but also
the type of tea consumed and the methods of preparation.
Our data are limited in that the number of ovarian can-
cer cases may have been insufficient to allow detection of
small effects. In addition, inaccurate recall of coffee and tea
consumption may have biased our estimates of association
towards the null (38). This limitation applies to previous
(prospective) studies as well. It is also possible that the use
of a one-time assessment of coffee and tea intake may not
have been representative of the consumption habits of the
study participants over the course of follow-up. If individ-
uals in the cohort changed their consumption patterns over
time, this may have resulted in misclassification of exposure.
Finally, although we adjusted our estimates for a wide range
of potentially confounding variables, residual confounding
by dietary and other factors cannot be excluded.
In conclusion, the results of our study suggest that while
tea intake was not associated with ovarian cancer risk,
relatively high coffee intake may be associated with an
increase in risk. Given the pervasive use of these beverages
and biologic support for possible carcinogenic (for coffee) or
anti-carcinogenic (for tea) effects, the associations between
coffee and tea consumption and ovarian cancer risk warrant
investigation in further prospective studies, particularly those
Vol. 58, No. 1 25
in which type of beverage and methods of preparation are
assessed.
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